Synapse - Robert Maki

Results (241)

Molecular basis for primary and secondary tyrosine kinase inhibitor resistance in gastrointestinal stromal tumor

Journal Article

Gounder, M. M.; Maki, R. G.
Cancer Chemotherapy and Pharmacology (2011)

Dermatofibrosarcoma protuberans (DFSP): Predictors of recurrence and the use of systemic therapy

Journal Article

Fields, R. C.; Hameed, M.; Qin, L. X.; Moraco, N.; Jia, X.; Maki, R. G.; Singer, S.; Brennan, M. F.
Annals of Surgical Oncology (2011)

Fulltext@MSK | Save

A phase II, randomized, controlled trial of palifosfamide plus doxorubicin versus doxorubicin in patients with soft tissue sarcoma (PICASSO)

Meeting Abstract

Verschraegen, C. F.; Chawla, S. P.; Mita, M. M.; Ryan, C. W.; Blakely, L.; Keedy, V. L.; Santoro, A.; Buck, J. Y.; Maki, R. G.; Lewis, J. J.; more...
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Pharmacokinetics (PK) of PF-02341066, a dual ALK/MET inhibitor after multiple oral doses to advanced cancer patients

Meeting Abstract

Tan, W.; Wilner, K. D.; Bang, Y.; Kwak, E. L.; Maki, R. G.; Camidge, D. R.; Solomon, B. J.; Ou, S. I.; Salgia, R.; Clark, J. W.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Direct visualization of circulating sarcoma cells by whole-blood fluoresence in situ hybridization

Meeting Abstract

Morozov, A.; Leversha, M.; Keohan, M.; D'Adamo, D. R.; Schwartz, G. K.; Meyers, P. A.; Maki, R. G.; Moore, M. A.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Adjuvant treatment of high-risk primary uterine Ieiomyosarcoma with gemcitabine/docetaxel (GT), followed by doxorubicin (D): Results of phase II multicenter trial SARC005

Meeting Abstract

Hensley, M. L.; Wathen, K.; Maki, R. G.; Araujo, D. M.; Sutton, G.; Priebat, D. A.; George, S.; Baker, L. H.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Activity of sorafenib against desmoid tumor/deep fibromatosis (DT/DF)

Meeting Abstract

Gounder, M. M.; Antonescu, C.; Hameed, M. R.; D'Adamo, D. R.; Keohan, M.; Singer, S.; Brennan, M. F.; Ahn, L. S.; Maki, R. G.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Outcomes of patients (pts) with advanced soft-tissue sarcomas (STS) treated in clinical trials (CTs) versus expanded access programs (EAPs): A decade of experience with single-agent trabectedin (Tr)

Meeting Abstract

Demetri, G. D.; Blay, J.; Schoffski, P.; Maki, R. G.; Yovine, A. J.; Judson, I. R.; Casali, P. G.; Gomez, J.; Bayever, E.; Le Cesne, A.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Systemic therapy in clear cell sarcoma

Meeting Abstract

Constantinidou, A.; Jones, R. L.; Al-Muderis, O.; Thway, K.; Ashley, S.; Scurr, M. R.; D'Adamo, D. R.; Keohan, M.; Maki, R. G.; Judson, I. R.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Relation of tumor pathologic and molecular features to outcome after surgical resection of localized primary gastrointestinal stromal tumor (GIST): Results of the intergroup phase III trial ACOSOG Z9001

Meeting Abstract

Corless, C. L.; Ballman, K. V.; Antonescu, C.; Blanke, C. D.; Blackstein, M. E.; Demetri, G. D.; von Mehren, M.; Maki, R. G.; Pisters, P. W.; DeMatteo, R. P.; more...
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save